MEK1/2 inhibitors activate IL-5 production both in vitro and in vivo.
MEK1/2 inhibitors induce IL-5 expression by activating IL-5 transcription and enhancing IL-5 protein stability.
Induction of IL-5 production may make contribution to the anti-atherogenic properties of MEK1/2 inhibitors.